Bone mineral density in adult patients with pyruvate kinase deficiency on long-term mitapivat treatment

• Hanny Al-Samkari,
• Rachael F. Grace,
• Andreas Glenthøj,
• Oliver Andres,
• Wilma Barcellini,
• Frédéric Galacteros,
• Kevin H. M. Kuo,
• D. Mark Layton,
• Marta Morado,
• Vip Viprakasit,
• Feng Tai,
• Rolandas Urbstonaitis,
• Jaime Morales,
• Bryan McGee,
• Eduard J. van Beers

Affiliations

Hanny Al-Samkari

Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Rachael F. Grace

Dana-Farber/Boston Children’s Cancer and Blood Disorder Center, Harvard Medical School, Boston, MA

Andreas Glenthøj

Department of Hematology, Rigshospitalet, Copenhagen

Oliver Andres

Department of Paediatrics, University of Würzburg, Würzburg

Wilma Barcellini

Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan

Frédéric Galacteros

Unité des Maladies Génétiques du Globule Rouge, CHU Henri-Mondor AP-HP, Créteil

Kevin H. M. Kuo

Division of Hematology, University of Toronto, Toronto, ON

D. Mark Layton

Hammersmith Hospital, Imperial College Healthcare NHS Foundation Trust

Marta Morado

Hematology Department, Hospital Universitario La Paz, Madrid

Vip Viprakasit

Siriaj Hospital, Mahidol University, Bangkok

Feng Tai

Agios Pharmaceuticals, Inc., Cambridge, MA

Rolandas Urbstonaitis

Agios Pharmaceuticals, Inc., Cambridge, MA

Jaime Morales

Agios Pharmaceuticals, Inc., Cambridge, MA

Bryan McGee

Agios Pharmaceuticals, Inc., Cambridge, MA

Eduard J. van Beers

Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht